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2 Principles of Differentiation and Morphogenesis
SCOTT F. GILBERT AND RITVA RICE
Developmental biology is the science connecting genetics with anatomy, making sense out of both. The body builds itself from 
the instructions of the inherited DNA and the cytoplasmic system that 
interprets the DNA into genes and creates intracellular and cellular 
networks to generate the observable phenotype. Even ecological fac­
tors such as diet and stress may modify the DNA such that different 
phenotypes can be constructed from the same DNA. During the past 
two decades, the basic principles of development have become known; 
although this brief chapter cannot do them justice (see, for example, 
Gilbert, 2013), they cover the following:
• Mechanisms of differential gene expression 
• Combinatorial logic of enhancers and promoters 
• Signal-transduction pathways linking cell membrane and nucleus 
• Mechanisms by which syndromes occur
• The repertoire of morphogenetic interactions and the molecules 
causing them
• Environmental agents of phenotype production
MECHANISMS OF DIFFERENTIAL GENE EXPRESSION
With few exceptions (e.g., lymphocytes and blood cells), every cell 
nucleus in the body contains the complete genome established in the 
fertilized egg. In molecular terms, the DNAs of all differentiated cells 
within an organism are identical. This was vividly demonstrated when 
entire mammalian organisms were generated from the nuclei of adult 
cells transplanted into enucleated oocytes (Wilmut et al., 1997; Kato 
et al., 1998; Wakayama et al., 1998), Thus the unused genes in differ­
entiated cells are neither destroyed nor mutated and retain the poten­
tial for being expressed. Only a small percentage of the genome is 
expressed in each cell, and a portion of the RNA synthesized in a cell 
is specific for that cell.
How, then, is the inherited repertoire of genes differentially expressed 
during development? It appears that this can be accomplished at the 4 
major steps of protein synthesis. Some genes are regulated at different 
steps in different cells, and certain genes can be regulated at multiple 
steps in the same cell:
• Differential gene transcription, regulating which of the nuclear 
genes are transcribed into nuclear (n)RNA 
• Selective nRNA processing, regulating which of the transcribed 
RNAs (or which parts of such an nRNA) enter into the cytoplasm to 
become messenger (m)RNAs
• Selective mRNA translation, regulating which of the mRNAs in the 
cytoplasm become translated into proteins 
• Differential protein modification, regulating which proteins are 
allowed to remain or function in the cell
DIFFERENTIAL GENE TRANSCRIPTION
Initiation of Transcription: Promoters and Enhancers
Whether or not a gene is active depends upon RNA polymerase bind­
ing to the promoter and the elongation of that RNA transcript. RNA 
polymerase II, the enzyme responsible for the transcription of protein­
encoding genes, does not bind directly to naked DNA. Rather, it binds 
to a number of proteins, including TFIID, which creates a saddle 
upon which it sits, and TFIIB, which positions RNA polymerase II 
on the DNA in such a manner that it can read the codons. Other basal
transcription factors, such as TFHA and TFIIH, help stabilize the poly­
merase once it is there (Kostrewa et al. 2009).
Where and when a gene is expressed depends on another regula­
tory unit of the gene, the enhancer. An enhancer is a DNA sequence 
that can activate or repress the utilization of a promoter, controlling 
the efficiency and rate of transcription from that particular promoter. 
Enhancers can activate only cA-linked promoters (i.e., promoters on 
the same chromosome), but they can do so at great distances (some as 
great as 50 kb away from the promoter). Moreover, enhancers do not 
need to be upstream of the gene. They can also be at the 3' end, in the 
introns, or even on the complementary DNA strand (Maniatis et al., 
1987). Like promoters, enhancers function by binding transcription 
factors, but these transcription factors are often very specific and are 
not found in every cell. As we will see, the combination of transcrip­
tion factors activates or represses gene transcription. It is estimated 
(Rockman and Wray, 2002) that the human species has more poly­
morphism in its regulatory regions than in the amino acid encoding 
exon regions of the genome, and mutations in the enhancer and pro­
moter regions are major causes of human congenital anomalies (see 
VanderMeer and Ahituv, 2011).
Enhancer-bound transcription factors work in two basic (and non­
exclusionary) ways. First, transcription factors recruit enzymes that 
modify the histone proteins that form the nucleosomes surrounding the 
DNA. Enzymes such as histone acetyltransferases chemically modify 
the histone proteins in ways that usually cause the dispersion of the 
nucleosomes in the area. Histone methyltransferases, however, often 
increase the stability of the nucleosomes and thereby repression of the 
gene. Second, they can bind to a large multimeric complex called the 
Mediator, whose nearly 30 protein subunits bind it to RNA polymerase II 
and relay developmental signals (Malik and Roeder 2010.) This forms 
the preinitiation complex at the promoter. The enhancer, with its bound 
transcription factors, is thought to loop around to contact the transcrip­
tion factors at the promoter site. Most genes have several enhancers, 
enabling them to be expressed in multiple tissues (Figure 2). Within 
each enhancer, however, there are usually several transcription factor­
binding sites, and the enhancer does not function unless many sites are 
occupied simultaneously.
Moreover, enhancers must be told where to stop. Since enhancers 
can work at relatively long distances, it is possible for them to acti­
vate several nearby promoters. To stop this spreading of the enhancer’s 
power, there are insulator sequences in the DNA (Zhou et al., 1995; 
Bell et al., 2001). Insulators bind proteins that prevent the enhancer 
from activating an adjacent promoter. They are often between the 
enhancer and a particular promoter. For instance, the chick p-globin 
enhancers are located in the locus control region (LCR), which is 
limited by insulators on both sides. On one side is an insulator that 
prevents the LCR enhancers from activating odorant receptor genes 
(which are active in the nasal neurons) and on the other side is an 
insulator preventing the LCR from activating the folate receptor gene.
Transcription Factors
Transcription factors are proteins that bind to enhancer or promoter 
regions and interact to activate or repress the transcription of a par­
ticular gene. Most transcription factors can bind to specific DNA 
sequences. These proteins can be grouped into families based on simi­
larities in structure (Table 2-1). The transcription factors within such 
a family share a framework structure in their DNA-binding sites, and
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BOX HOXA-1, HOXB-2, etc. Axis formation
POU PlTl, Unc-86, Oct-2 Pituitary development, neural 
fate
LIM Lim-1 Head development
PAX PAXl,-2,-3, etc. Neural specification, eye 
development
Forkhead/winged FOXC1 Eye and skeletal development
helix
Basic helix-loop- MYOD, achaete Muscle and nerve specification
helix
Basic leucine C/EBP, API Liver differentiation, fat cell
zipper specification
ZINC FINGER
Standard WTLKruppel Kidney, gonad development
Hormone Estrogen receptor Secondary sex determination
receptors
Sry-Sox Sry, SOXD, Sox2 Bone, primary sex 
determination
slight differences in the amino acids at the binding site can alter the 
sequence of the DNA to which the factor binds.
Transcription factors have three major domains. The first is a DNA- 
binding domain, which recognizes a particular DNA sequence. The 
second is a fran^-activating domain, which activates or suppresses the 
transcription of the gene whose promoter or enhancer it has bound. 
Usually, the frani-activating domain enables the transcription fac­
tor to interact with proteins involved in binding RNA polymerase 
(e.g., TFIIB or TFIIE; see Sauer et ah, 1995) or with nucleosome- 
remodeling enzymes that regulate the access of RNA polymerase to 
the promoter. In addition, there may be a protein-protein interaction 
domain, which allows the transcription factor’s activity to be modu­
lated by other transcription factors.
Transcription factors can also be grouped together based on their 
function. Constitutively active nuclear transcription factors are found 
in all cells at all times, and many are essential to the initiation of tran­
scription. For instance, the basal transcription factors belong to this 
group. Regulatory transcription factors require activation to function. 
Some of these proteins are specific to particular cell types or specific 
temporal stages of development. Others are present ubiquitously but 
cannot function without being activated (often by the paracrine fac­
tor signaling cascades discussed further on) (Brivanlou and Darnell, 
2002). It is the combinatorial use of transcription factors that is the 
driving force behind gene-specific transcription and eventually differ­
entiation and morphogenesis.
Numerous diseases are caused by deficiencies of transcription fac­
tors. The first identified, transcription factoropathy, was probably the 
androgen insensitivity syndrome. Here the testosterone receptor, a 
dormant transcription factor, is absent or deficient and therefore will 
not bind to the DNA activating male-specific genes, even in the pres­
ence of its activator, testosterone (Meyer et ah, 1975). One of the first 
human genetic diseases to be understood from the binding of the ligand 
to the receptor through the activation of chromatin was Waardenburg 
syndrome type II. Here, people heterozygous for the wild-type copy of 
microphthalmia (MITF) are deaf, have multicolored irises, and have 
a white forelock in their hair. Activation of this transcription factor 
through the protein tyrosine kinase cascade enables it to dimerize, to 
bind to the regulatory regions of particular genes, and to bind a histone 
acetyltransferase that opens a region of DNA for transcription (Figure 2; 
see Chapter 128).
Combinatorial Control of Transcription
The binding of a specific transcription factor to the enhancer or pro­
moter does not ensure that that gene will be transcribed. Although 
“master regulatory genes” such as PAX6 (eye) or MYOD (muscles)
have been proposed, even they work in concert with other transcrip­
tion factors to effect cell differentiation. The use of PAX6 by different 
organs demonstrates the modular nature of transcriptional regulatory 
units. The PAX6 transcription factor is needed for mammalian eye, 
nervous system, and pancreatic development; mutations in the human 
PAX6 gene cause severe nervous system, pancreatic, and optic abnor­
malities (Glaser et ah, 1994; see Chapters 8 and 112). Pax6 binding 
sequences have been found in the enhancers of vertebrate lens crys- 
tallin genes and in the genes expressed in the endocrine cells of the 
pancreas (insulin, glucagon, and somatostatin).
Transcription factors work in concert with other transcription fac­
tors to activate a particular gene. For instance, in the chick 61 lens 
crystallin gene, Pax6 works with Sox2, Maf-1, and Spl. Spl is a gen­
eral transcriptional activator found in all cells. Pax6 is found early 
in development throughout the head ectoderm. Sox2 is found only 
in those tissues that will become lens, and it is induced by the pre­
sumptive retina when the developing retinal cells contact the outer 
ectoderm. Thus only those cells that contain both Sox2 and Pax6 can 
express the lens crystallin gene. The association of the Pax6, Sox2, and 
Maf-1 transcription factors on the enhancer of the genes in lens cells 
recruits a histone acetyltransferase that can transfer acetyl groups to 
the histones and dissociate the nucleosomes in that area to activate the 
crystallin genes (Yang et al. 2007). In addition, there is a third site that 
can bind either an activator (the 6EF3 protein) or a repressor (the 8EF1 
protein) of transcription. It is thought that the repressor may be critical 
in preventing crystallin expression in the nervous system.
Other regulatory regions that use Pax6 are the enhancers regulating 
the transcription of the insulin, glucagon, and somatostatin genes of 
the pancreas. Here, Pax6 cooperates with other transcription factors 
such as Pdxl (specific for the pancreatic region of the endoderm) and 
Pbxl (Andersen et ah, 1999; Hussain and Habener, 1999; Lammert 
et ah, 2001). New technologies (such as chromatin immunoprecipita- 
tion) have identified numerous important interactions whereby tran­
scription factors stabilize each other’s binding and function together to 
activate gene expression (see Wilson et ah, 2010).
Pax6 also binds to the regulatory regions of the PAX6 gene itself 
(Plaza et ah, 1993). This means that once the PAX6 gene is turned on, it 
will continue to be expressed even if the signal that originally activated 
it is no longer given.
Thus 4 principles can be seen here: (1) transcription factors func­
tion in a combinatorial manner, wherein several work together to pro­
mote or inhibit transcription. (2) There are 2 major routes by which 
transcription factors become present in the nucleus: (a) through cell 
lineage, where the presumptive lens tissue acquires its Pax6 by being 
the head ectoderm and the presumptive pancreatic islets acquire Pdxl 
through their being endodermal, and (b) through induction, as when 
the Sox2 gene becomes expressed when the presumptive retina abuts 
the presumptive lens. (3) Transcription factors can continue to be 
synthesized after the original signal for their synthesis has ceased. 
(4) Another principle is seen in the example of MITF, mentioned pre­
viously: the mere presence of transcription factors in the cell is often 
insufficient for their binding to DNA and consequently functioning. 
Often, they have to be activated posttranslationally to function. MITF 
has to be phosphorylated in order to function as a transcription factor. 
When this activation occurs, it dimerizes and can bind an acetyltrans­
ferase which promotes gene expression by getting rid of nucleosomes 
in the vicity of the gene. The activation of dormant transcription fac­
tors is a major mechanism for the control of differentiation and mor­
phogenesis; we will return to it later.
Although transcription factors are critical in activating genes, there 
appear to be two major classes of gene in the cell; the transcription 
factors may operate differently in these two classes. Low-CpG-content 
promoters (i.e., promoters characterized by a relatively low level of the 
nucleotide pair CpG) are usually found in those genes whose products 
characterize mature cells (e.g., the globins of red blood cells, the hor­
mones of pancreatic cells, and the enzymes that carry out the normal 
maintenance functions of the cell). Their CpG sites are often methyl­
ated; this recruits enzymes that methylate the histones and keep the 
gene repressed. Therefore the default state of these promoters is “off.” 
These genes can be activated when the methyl groups are removed
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Observation
mRNA expressed 
in brain and limb
Modei
Fig. 2-1. Enhancer function and modularity. In this example, a gene is 
expressed in the brain and in the limbs (A). In developing brain cells (B), tran­
scription factors found in the brain cells bind to the “brain enhancer,” causing 
it to bind to the Mediator complex, stabilize RNA polymerase at the promoter, 
and modify the nucleosomes in the region of the promoter. The limb enhancer
does not function, and the gene is transcribed in the brain cells. (C) In the limb, 
a similar process allows for transcription of the same gene in the limb cells. The 
gene is not transcribed in any cell type not containing transcription factors the 
enhancers of this gene can bind.
Source: After Visel et al., 2009.
from the DNA. This is very important in genomic imprinting, where 
DNA from the sperm or egg is differentially methylated such that tran­
scription occurs only from the maternally or paternally derived gene.
High-CpG-content promoters are characteristic of the developmen­
tal regulatory genes that regulate cell fate. The DNA of these promot­
ers is relatively unmethylated, and nucleosomes tend to be enriched 
with “activating” residues. As a result, these promoters usually have an 
RNA polymerase II protein already present on them (Hon et al 2009; 
Ernst and Kellis 2010). Indeed, there is often a small, truncated, tran­
script of nRNA already initiated (but not completed) at these promot­
ers. DNA methylation does not appear to play a major role in regulating 
these promoters. Rather, the HCPs can be repressed by modifying the 
histone 3 to H327me3, which recruits polycomb repressive complex 
2 (Peng et al., 2009; Li et al, 2010). This complex appears to inhibit 
further RNA polymerase binding as well as preventing the elongation 
of the existing nRNA transcripts. The rate-limiting step at these pro­
moters is RNA elongation, which is regulated by another set of tran­
scription factors.
OTHER MECHANISMS OF DEVELOPMENTAL 
GENE REGULATION
Regulation of gene expression is not confined to the differential tran­
scription of DNA. Even if a particular RNA transcript is synthesized, 
there is no guarantee that it will create a functional protein in the cell. 
To become an active protein, the mRNA must be (1) processed into 
mRNA by the removal of introns, (2) translocated from the nucleus 
to the cytoplasm, and (3) translated by the protein-synthesizing
apparatus. In some cases, the synthesized protein is not in its mature 
form and (4) must therefore be posttranslationally modified to become 
active. Regulation can occur at any of these steps during development.
Differential Nuclear RNA Processing
In bacteria, differential gene expression can be effected at the levels 
of transcription, translation, and protein modification. In eukaryotes, 
however, another possible level of regulation exists: control at the level 
of RNA processing and transport. There are 2 major ways in which 
differential RNA processing can regulate development. The first 
involves “censoring,” determining which nuclear transcripts will be 
processed into cytoplasmic messages. Here different cells can select 
different nuclear transcripts to be processed and sent to the cytoplasm 
as mRNA. The same pool of nuclear transcripts can thereby give rise 
to different populations of cytoplasmic mRNAs in different cell types. 
The second mode of differential RNA processing is the splicing of the 
mRNA precursors into messages for different proteins, using different 
combinations of potential exons. If an mRNA precursor had 5 poten­
tial exons, 1 cell might use exons 1, 2, 4, and 5; a different cell might 
utilize exons 1, 2, and 3; and yet another cell type might use a different 
combination. Thus one gene can create a family of related proteins by 
alternative RNA splicing (Nilsen and Graveley, 2010).
This ability to create large numbers of proteins from 1 gene through 
differential exon splicing may be extremely important in human devel­
opment. It is estimated that 92% of human genes have multiple types 
of mRNA. Therefore even though the human genome may contain 
20,000 to 30,000 genes, its proteome—the number and type of pro­
teins encoded by the genome—is far more complex. “Human genes
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are multitaskersnotes Christopher Burge, one of the scientists who 
calculated this figure (Ledford, 2008). Whether a sequence of RNA is 
recognized as an exon or as an intron is a crucial step in gene regula­
tion. What is an intron in one cell’s nucleus may be an exon in another 
cell’s nucleus.
In some instances alternatively spliced RNAs yield proteins that play 
similar yet distinguishable roles in the same cell. Pax6 has two splic­
ing isoforms, and each is needed for different roles in the body. They 
cannot compensate for each other (Epstein et al., 1994). Similarly, dif­
ferent isoforms of the WTl protein perform different functions in the 
development of the gonads and kidneys. The isoform without the extra 
exon functions as a transcription factor during testis development, 
whereas the isoform containing the extra exon appears to be a splicing 
factor involved in kidney development (Hastie, 2001).
Thus proper development means not only that genes are tran­
scribed at the appropriate time but also that the nuclear gene products 
are spliced appropriately. Mutations in the splice sites of genes can 
therefore prevent certain isoforms from arising, and it is estimated 
that 15% of all point mutations that result in human genetic disease 
are those creating splice site abnormalities (Krawczak et al., 1992; 
Cooper and Mattox, 1997). For instance, a single base change at 
the 5’ end of intron 2 in the human P-globin gene prevents splicing 
from occurring and generates a nonfunctional mRNA (Baird et al., 
1981). Thus there is no p-globin from this gene, leading to a severe 
(and often life-threatening) type of anemia. Similarly, a mutation in 
the dystrophin gene at a particular splice site causes the skipping 
of that exon and a severe form of muscular dystrophy (Sironi et al., 
2001). Congenital adrenal hypoplasia can be caused by a point muta­
tion in the splice site for the second intron of the CYP21 gene for 
21-hydroxylase.
Some proteins and small nuclear RNAs are used throughout the 
body to effect differential pre-mRNA splicing, and there are some pro­
teins that appear to be cell type-specific, regulating differential splic­
ing in a manner characteristic for that cell. If the genes encoding these 
cell set-specific splicing factors are mutated, one could expect several 
cell-specific isoforms to be aberrant. This appears to be the case in the 
leading cause of hereditary infant mortality, spinal muscular atrophy. 
Here mutations in the gene encoding the survival of motor neurons 
(SMNs) protein prevent the maintenance of motor neurons. This pro­
tein is involved in splicing nRNAs in this subset of neurons (Pellizzoni 
et al, 1999).
RNA Translation
Once a message has been transcribed and properly spliced, it can 
enter the cytoplasm and be translated. However, translation is an intri­
cately regulated mechanism that may also alter phenotypes. Some 
genetic diseases are due to mutations that create termination codons. 
For instance, a complete form of androgen insensitivity syndrome is 
caused by a guanine-to-adenine transition at nucleotide 2682, chang­
ing codon 717 from tryptophan to a translation stop signal (Sai et al., 
1997). Codon 717 is in exon 4, and this truncated receptor thereby 
lacks most of its androgen-binding domain. Other mutations can alter 
the longevity of an mRNA, which can greatly affect the number of 
proteins synthesized from it. For example, hemoglobin a-Constant 
Spring is a naturally occurring mutation wherein the translation ter­
mination codon has been mutated to that of an amino acid codon, and 
the translation continues for 31 more codons (Wang et al., 1995). This 
readthrough results in the destabilization of the a-globin mRNA, a 
reduction of greater than 95% of a-globin gene expression from the 
affected locus and the resultant clinical disease (a-thalassemia).
In many instances, certain messages are stabilized or brought to the 
ribosomes by certain proteins. The most prevalent form of inherited 
mental retardation, fragile X syndrome, may result from the transla­
tional deficiency of certain neuronal messages. This disease usually 
results from the expansion and hypermethylation of CGG repeats in 
the 5'-untranslated region of the FMRl gene, which blocks transcrip­
tion of this gene. FMRl encodes an RNA-binding protein, which 
appears to be critical for the translation of certain messages. Almost 
85% of the FMRl protein is associated with translating polysomes, 
whereas mutants in the RNA-binding domains produce severe forms
of the syndrome and are not observed with the cytoplasmic polysomes 
(Feng et al., 1997a,b). Several studies (Brown et al, 2001; Darnell 
et al., 2001; Antar et al., 2006) have shown that a particular subset 
of mouse brain mRNA requires this protein for proper translation. 
Most of these genes are involved with synapse function or neuronal 
development. It is probable that fragile X mental retardation protein 
(FMRP) binds to specific mRNAs, either regulating their translation 
or targeting them to the dendrite, where they might await the signal 
for translation.
Posttranslational Modification
When a protein is synthesized, the story is still not over. Once a protein 
is made, it becomes part of a larger level of organization. For instance, 
it may become part of the structural framework of the cell, or it may 
become involved in one of the myriad enzymatic pathways for the syn­
thesis or breakdown of cellular metabolites. In any case, the individual 
protein is now part of a complex “ecosystem,” which integrates it into 
a relationship with numerous other proteins. Thus several changes can 
still take place that determine whether the protein will be active. Some 
newly synthesized proteins are inactive without the cleaving away of 
certain inhibitory sections. This is what happens when insulin is made 
from its larger protein precursor. Some proteins must be “addressed” 
to their specific intracellular destinations to function. Proteins are 
often sequestered in certain regions, such as membranes, lysosomes, 
nuclei, or mitochondria; specific amino acid sequences are needed 
either as recognition sequences or as places for such tags. For instance, 
mucolipidosis II (I-cell disease) is characterized by a deficiency in the 
mannose-6-phosphate “address tag” put onto enzymes to target them 
to the lysosome. Here, there is a deficiency in GlcNAc-1-P transferase, 
which is involved in constructing the mannose-6-phosphate residues 
(Sly and Fischer, 1982).
Some proteins must assemble with other proteins in order to form 
a functional unit. The hemoglobin protein, the microtubule, and the 
ribosome are all examples of numerous proteins joining together to 
form a functional unit. Diseases such as sickle cell anemia and certain 
types of osteogenesis imperfecta syndrome are caused by the improper 
assembly of protein subunits. Moreover, some proteins are not active 
unless they bind an ion, such as calcium, or are modified by the cova­
lent addition of a phosphate or acetate group. This last type of protein 
modification will become very Important in the following section as 




Organs are complex structures composed of numerous types of tis­
sue. In the vertebrate eye, for example, light is transmitted through the 
transparent comeal tissue and focused by the lens tissue (the diameter 
of which is controlled by muscle tissue), eventually impinging on the 
tissue of the neural retina. The precise arrangement of tissues in this 
organ cannot be disturbed without impairing its function. Such coordi­
nation in the constmction of organs is accomplished by one group of 
cells changing the behavior of an adjacent set of cells, thereby causing 
them to change their shape, mitotic rate, or fate. This kind of interac­
tion at close range between two or more cells or tissues of different 
history and properties is called proximate interaction or induction. 
There are at least two components to every inductive interaction. The 
first is the inducer, the tissue that produces a signal (or signals) that 
changes the cellular behavior of the other tissue, and the second is the 
responder, the tissue being induced.
Not all tissues can respond to the signal being produced by the 
inducer. For instance, if the optic vesicle (presumptive retina) of 
Xenopus laevis is placed in an ectopic location (i.e., in a different 
place from where it normally forms) underneath the head ectoderm, 
it will induce that ectoderm to form lens tissue. Only the optic vesicle 
appears to be able to do this; therefore it is an inducer. However, if the 
optic vesicle is placed beneath the ectoderm in the flank or abdomen 
of the same organism, that ectoderm will not be able to respond. Only
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the head ectoderm is competent to respond to signals from the optic 
vesicle by producing a lens (Saha et al., 1989; Grainger, 1992).
This ability to respond to a specific inductive signal is called com­
petence (Waddington, 1940); this is not a passive state but an actively 
acquired condition. For example, in the developing chick and mam­
malian eye, the Pax6 protein appears to be important in making the 
ectoderm competent to respond to the inductive signal from the 
optic vesicle. Pax6 expression is seen in the head ectoderm, which 
can respond to the optic vesicle by forming lenses; and it is not seen 
in other regions of the surface ectoderm (Li et al., 1994). Moreover, 
the importance of Pax6 as a competence factor was demonstrated by 
recombination experiments using embryonic rat eye tissue (Fujiwara 
et al., 1994). Pax6 is required for the surface ectoderm to respond to 
the inductive signal from the optic vesicle; the inducing tissue does 
not need it. Pax6 is expressed in the anterior ectoderm of the embryo 
through the interaction of the lateral dorsal head ectoderm with the 
anterior neural plate (Zygar et al., 1998).
Induction is a multilevel and sequential series of activations, 
whereby an early activation may give the cell the competence to 
respond to later signals. Thus there is no single “inducer of the lens.” 
Studies on amphibians suggest that the first lens inducers may be the 
pharyngeal endoderm and heart-forming mesoderm, which underlie 
the lens-forming ectoderm during the early and midgastrula stages 
(Jacobson, 1966). The anterior neural plate may produce the next sig­
nals, including a signal that promotes the synthesis of Pax6 in the ante­
rior ectoderm. Thus, while the optic vesicle appears to be the inducer, 
the anterior ectoderm has already been induced by at least 2 other 
factors. (This situation is like that of the player who kicks the “win­
ning goal” of a soccer match.) The optic vesicle appears to secrete 2 
induction factors; 1 appears to be BMP4 (Furuta and Hogan, 1998), a 
paracrine factor protein that induces the transcription of the Sox2 and 
Sox3 transcription factors, and the other is thought to be FGF8, a para­
crine factor that induces the appearance of the L-Maf transcription fac­
tor (Ogino and Yasuda, 1998; Vogel-Hopker et al., 2000; Ogino et al., 
2012). The combination of Pax6, Sox2, Sox3, and L-Maf ensures the 
production of the lens.
Cascades of Induction: Reciprocal 
and Sequential Inductive Events
Another feature of induction is the reciprocal nature of many induc­
tive interactions. Once the lens has begun forming, it can induce other 
tissues. One of these responding tissues is the optic vesicle itself. 
Now the inducer becomes the induced. Under the influence of fac­
tors secreted by the lens, the optic vesicle becomes the optic cup and 
the wall of the optic cup differentiates into two layers, the pigmented 
retina and the neural retina (Cvekl and Piatigorsky, 1996). Such inter­
actions are called reciprocal inductions.
At the same time, the developing lens also induces the ectoderm 
above it to become the cornea. Like the lens-forming ectoderm, the 
comea-forming ectoderm has achieved a particular competence to 
respond to inductive signals, in this case the signals from the lens 
(Meier, 1977; Kanakubo et al 2006). Under the influence of the lens, 
the comeal ectodermal cells become columnar and secrete multiple 
layers of collagen. Mesenchymal cells from the neural crest use this 
collagen matrix to enter the area and secrete a set of proteins (includ­
ing the enzyme hyaluronidase), which further differentiate the cornea. 
A third signal, the hormone thyroxine, dehydrates the tissue and makes 
it transparent (Hay, 1979; Bard, 1990). Thus, there are sequential 
inductive events and multiple causes for each induction.
Instructive and Permissive Interactions
Howard Holtzer (1968) distinguished two major modes of inductive 
interaction. In instructive interaction, a signal from the inducing cell 
is necessary to initiate a new gene expression in the responding cell. 
Without the inducing cell, the responding cell would not be capable of 
differentiating in that particular way. For example, when the optic ves­
icle is experimentally placed under a new region of the head ectoderm 
and causes that region of the ectoderm to form a lens, it is an instruc­
tive interaction. The second type of induction is permissive interac­
tion. Here the responding tissue contains all the potentials that are to
be expressed and needs only an environment that allows expression of 
these traits. For instance, many tissues need a solid substrate contain­
ing fibronectin or laminin to develop. The fibronectin or laminin does 
not alter the type of cell that is to be produced but only enables what 
has been determined to be expressed.
Regional Specificity of Induction
Some of the best-studied cases of induction are those involving the 
interactions of sheets of epithelial cells with adjacent mesenchymal 
cells. These interactions are called epithelial-mesenchymal interac­
tions. Epithelia are sheets or tubes of connected cells; they can origi­
nate from any germ layer. Mesenchyme comprises loosely packed cells 
derived from the mesoderm or neural crest. All organs consist of an 
epithelium and an associated mesenchyme, so epithelial-mesenchy­
mal interactions are among the most important phenomena in develop­
ment. Some examples are listed in Table 2-2.
Using the induction of cutaneous structures as our examples, we 
will look at the properties of epithelial-mesenchymal interactions. The 
first of these properties is the regional specificity of induction. Skin is 
composed of two main tissues: an outer epidermis (an epithelial tis­
sue derived from the ectoderm) and a dermis (a mesenchymal tissue 
derived from the mesoderm). The chick epidermis signals the underly­
ing dermal cells to form condensations (probably by secreting sonic 
hedgehog and transforming growth factor (TGF)-p2 proteins, which 
will be discussed further on), and the condensed dermal mesenchyme 
responds by secreting factors that cause the epidermis to form region­
ally specific cutaneous structures (Nohno et al., 1995; Ting-Berreth 
and Chuong, 1996). These structures can be the broad feathers of 
the wing, the narrow feathers of the thigh, or the scales and claws 
of the feet. Researchers can separate the embryonic epithelium and 
mesenchyme from each other and recombine them in different ways 
(Saunders et al., 1957), demonstrating that the dermal mesenchyme is 
responsible for the regional specificity of induction in the competent 
epidermal epithelium. The same type of epithelium develops cutane­
ous structures according to the region from which the mesenchyme 
was taken. Here the mesenchyme plays an instructive role, calling into 
play different sets of genes in the responding epithelial cells.
Tooth patterning is another set of processes driven by region-specific 
epithelial induction. Classical epithelial-mesenchymal transplantation 
studies have shown that early dental epithelium induces the under­
lying mesenchymal cells to become odontogenic (Mina and Kollar, 
1987). Mammoto et al. (2011) studied the mechanisms involved in the 
early patterning of the tooth both on the level of the organ and that of 
the single cell. They found that the early dental epithelium secretes 
Fgf8, which attracts underlying mesenchymal cells and causes them 
to migrate toward the source of Fgf8. The epithelium also secretes 
Sema3f, which repulses the migrating mesenchymal cells. At a cer­
tain distance from the early dental epithelium, the opposing epithelial 
morphogens cause the underlying mesenchymal cells to condense. 
This compaction of mesenchymal cells and the associated change in 
their cell shape alone is enough to induce mesenchymal expression 
of odontogenic-specific genes such as Pax9, Msxl, and Bmp4. This is 
mediated by the suppression of RhoA, a cytoskeletal signaling mol­
ecule that responds to mechanical cues. Thus early tooth patterning 
is achieved via chemical cues sent by the inductive epithelium to the
Table 2-2. Examples of Organs and Their Epithelial and Mesenchymal 
Components. ___________________________________ ______ _
Organ Epithelial Component Mesenchymal Component
Cutaneous appendages Epidermis (ectoderm) Dermis (mesoderm)
(hair, sweat glands) 
Gut organs Endodermal epithelium Mesodermal mesenchyme
Respiratory organs Endodermal epithelium Mesodermal mesenchyme







responding mesenchyme, causing it to condense. The condensed mes­
enchyme then continues independently to switch on the cell fate-spe­
cific gene expression by mechanotransduction. Once mesenchyme has 
acquired its odontogenic fate, tooth patterning continues via reciprocal 
inductions between the dental epithelium and mesenchyme.
AN INTRODUCTION TO SIGNAL-TRANSDUCTION 
PATHWAYS
Paracrine Factors
How are the signals between inducer and responder transmitted? While 
studying the mechanisms of induction that produce the kidney tubules 
and the teeth, Grobstein (1956) and others found that some inductive 
events could occur despite a filter separating the epithelial and mes­
enchymal cells. Other inductions, however, were blocked by the filter. 
The researchers therefore concluded that some of the inductive mol­
ecules were soluble factors that could pass through the small pores 
of the filter and that other inductive events required physical contact 
between the epithelial and mesenchymal cells. When cell membrane 
proteins on one cell surface interact with receptor proteins on adjacent 
cell surfaces, these events are called juxtacrine interactions (as the 
cell membranes are juxtaposed). When proteins synthesized by one 
cell can diffuse over small distances to induce changes in neighboring 
cells, the event is called a paracrine interaction, and the diffusible pro­
teins are called paracrine factors or growth and differentiation factors 
(GDFs). We will consider paracrine interactions first and then return to 
juxtacrine interactions later in this chapter.
Whereas endocrine factors (hormones) travel through the blood to 
exert their effects, paracrine factors are secreted into the immediate 
spaces around the cell producing them. These proteins are the “induc­
ing factors” of the classic experimental embryologists. During the past 
decade, developmental biologists have discovered that the induction of 
numerous organs is actually effected by a relatively small set of para­
crine factors. The embryo inherits a rather compact “tool kit” and uses 
many of the same proteins to construct the heart, kidneys, teeth, eyes, 
and other organs. Moreover, the same proteins are utilized throughout 
the animal kingdom; the factors active in creating the Drosophila eye 
or heart are very similar to those used in generating mammalian organs. 
Many of these paracrine factors can be grouped into four major fami­
lies on the basis of their structures: the fibroblast growth factor (FGF) 
family, the Hedgehog family, the Wingless (Wnt) family, and the TGF- 
P superfamily. Although most of the paracrine factors are members of 
these four families, some have few or no close relatives. Factors such 
as epidermal growth factor, hepatocyte growth factor, neurotrophins, 
and stem cell factor are not in the families mentioned previously, but 
each plays important roles during development. In addition, numer­
ous factors— erythropoietin, the cytokines, and the interleukins —are 
involved almost exclusively with developing blood cells.
Classically, paracrine signals have been considered to diffuse pas­
sively in extracellular space. Recent years have shown that in several 
organ systems signalling proteins are transported along transient spe­
cialized signalling filopodia called cytonemes. Cytonemes take envi­
ronmental cues from the extracellular matrix, and allow dynamic and 
precise secretion of signalling proteins to affect growth, differentiation 
and pattern formation (reviewed in Komberg and Roy, 2014; Roy and 
Komberg, 2014). Cytonemes extend to make contact with target cells, 
and disperse signalling proteins at sites of these cell-cell contacts. 
In Drosophila wing disc cytonemes have been shown to be respon­
sible for both short and long distance decapentaplegic (Dpp, a TGF-p 
family member) signalling; wing disc-associated tracheal branch air 
sac primordium has been shown to extend two types of cytonemes, 
one specific for Dpp signalling and another for FGF signalling (Roy 
et al., 2014).
Another mechanism for controlled transportation of signalling pro­
teins for short and long distances outside cells is their secretion in 
extracellular vesicles called exosomes that contain cytosol from the 
secreting cell surrounded by a lipid bilayer. Exosomes traffic pro­
teins, lipids, and RNA molecules. They are more stable than soluble 
protein in the extracellular matrix, and they make it easier to traffic
hydrophobic proteins like active Wnt proteins. Wnt proteins, at least 
in part, have been shown to be secreted and transported to recipient 
cells via exosomes in C. elegans, D. melanocaster, and in human cells 
(Kolotuev et al., 2009; Gross et al., 2012; Gross and Boutros, 2013).
Paracrine Factor Signaling Pathways
We now turn to the molecules involved in the response to induction. 
These molecules include the receptors in the membrane of the respond­
ing cell, which bind the paracrine factor, and the cascade of interacting 
proteins, which transmit a signal through a pathway from the bound 
receptor to the nucleus. These pathways between the cell membrane 
and the genome are called signal-transduction pathways', we will out­
line some of the major ones here. They appear to be variations on a 
common and rather elegant theme (Fig. 2): each receptor spans the cell 
membrane and has an extracellular region, a transmembrane region, 
and a cytoplasmic region. When a ligand (the paracrine factor) binds 
its receptor in the extracellular region, it induces a conformational 
change in the receptor’s structure. This shape change is transmitted 
through the membrane and changes the shape of the cytoplasmic 
domains. The conformational change in the cytoplasmic domains 
gives them enzymatic activity, usually a kinase activity that can use 
ATP to phosphorylate proteins, including the receptor molecule itself. 
The active receptor can now catalyze reactions that phosphorylate 
other proteins, and this phosphorylation, in turn, activates their latent 
activities. Eventually the cascade of phosphorylation activates a dor­
mant transcription factor, which activates (or represses) a particular set 
of genes. There are numerous modifications of this theme; some of the 
most important of these pathways are outlined in Fig. 2-2.
The RTK-Mitogen-Activated Protein Kinase Pathway
Fibroblast Growth Factors
Almost two dozen distinct FGF genes are known in -vertebrates, and 
they can generate hundreds of protein isoforms by varying their RNA 
splicing or initiation codons in different tissues (see Chapter 60). FGFs 
can activate a set of receptor tyrosine kinases (RTKs), the FGF recep­
tors (FGFRs). When the FGFR binds an FGF (and only when it does 
so), the dormant kinase is activated and it phosphorylates certain pro­
teins within the responding cell. The proteins are now activated and 
can perform new functions. FGFs are associated with several devel­
opmental functions, including angiogenesis (blood vessel formation), 
mesoderm formation, and axon extension. Although FGFs can often 
substitute for one another, their expression patterns give them separate 
functions. FGF2 is especially important in angiogenesis, and FGFS 
is important for the development of the midbrain, eyes, and limbs 
(Crossley et al., 1996).
The RTK signal-transduction pathway was one of the first pathways 
to unite various areas of developmental biology. Researchers studying 
Drosophila eyes, nematode vulvae, and human cancers found that they 
were all studying homologous genes. The RTK-mitogen-activated 
protein kinase (MAPK) pathway begins at the cell surface, where an 
RTK binds its specific ligand. Ligands that bind to RTKs include the 
FGFs, epidermd growth factors, platelet-derived growth factors, and 
stem cell factor. Each RTK can bind only one or a small set of these 
ligands (stem cell factor, for instance, will bind to only one RTK, the 
Kit protein). The RTK spans the cell membrane, and when it binds its 
ligand, it undergoes a conformational change that enables it to dimer­
ize with another RTK. This conformational change activates the latent 
kinase activity of each RTK, and these receptors phosphorylate each 
other on particular tyrosine residues. Heterozygous loss-of-function 
alleles of FGF receptors 2 and 3, which abolish this kinase activity, 
have been associated with lacrimo-auriculo-dento-digital (LADD) 
syndrome of lacrimal duct aplasia, deafness, digital anomalies, and 
small teeth (Rohmann et al., 2006). Thus the binding of the ligand 
to the receptor causes the autophosphorylation of the cytoplasmic 
domain of the receptor.
The phosphorylated tyrosine on the receptor is then recognized by 
an adapter protein complex (Fig. 2-lB). Such a complex serves as a 
bridge that links the phosphorylated RTK to a powerful intracellular






















































Fig. 2-2. Five of the major signal-transduction pathways through which sig­
nals on the cell surface are sent into the nucleus, (/i) The receptor tyrosine 
kinase-mitogen-activated protein kinase (RTK-MAPK) pathway, (B) the Smad 
pathway used by transforming growth factor-/) (TGF-/3) superfamily pro­
teins, iO the JAK-STAT pathway, (D) the Wnt pathway, (£) the Hedgehog
pathway, and (F) one of the apoptosis pathways used by mammalian neu­
rons. Abbreviations'. ERK, extracellular signal—regulated kinase, GNRP, 
guanine nucleotide-releasing protein; GSK, glycogen synthase kinase; JAK, 
Janus kinase; MEK, MAPK kinase; STAT, signal transducer and activator of 
transcription.
signaling system. While binding to the phosphorylated RTK through 
one of its cytoplasmic domains, the adapter protein also activates a 
G protein (see Chapter 60). Normally the G protein is in an inactive 
GDP-bound state. The activated receptor stimulates the adapter pro­
tein to activate the guanine nucleotide-releasing factor. This protein 
exchanges a phosphate from a GTP to transform the bound GDP into 
GTP. The GTP-bound G protein is an active form that transmits the sig­
nal. After delivering the signal, the GTP on the G protein is hydrolyzed 
back into GDP. This catalysis is greatly stimulated by the complexing 
of the Ras protein with the GTPase-activating protein (GAP). In this 
way, the G protein is returned to its inactive state, where it can await 
further signaling. Mutations in the genes encoding the small GTP- 
binding proteins and their regulators can lead to cancers or syndromes 
such as Aarskog-Scott syndrome, fibrous dysplasia, and neurofibro­
matosis I (see Chapters 180, 179, and 80). The Costello syndrome is 
caused by mutations in the HRAS small G protein (Aoki et al., 2005; 
Estep et al., 2006; Gripp et al., 2006), and Noonan syndrome is asso­
ciated with missense mutations of the PTPNll gene (which encodes 
the SHP2 protein serving as part of the adapter complex in certain cell 
types (Tartaglia et al., 2001; see Chapter 81).
The active G protein associates with a kinase called Raf. The G 
protein recruits the inactive Raf protein to the cell membrane, where 
it becomes active (Leevers et al., 1994; Stokoe et al., 1994). The Raf 
protein is a kinase that activates the MAPK kinase (MEK) protein by 
phosphorylating it. MEK is itself a kinase, which activates extracellu­
lar signal-regulated kinase (ERK) by phosphorylation, and phosphory­
lated ERK is a kinase that can enter the nucleus and phosphorylate 
certain transcription factors. This pathway is critical in numerous 
developmental processes, and mutations in the genes encoding MEK 
or RAE kinases can cause cardiofaciocutaneous syndrome (Rodriguez- 
Viciana et al., 2006; see Chapter 83).
In the migrating neural crest cells of humans and mice, the RTK 
pathway is important in activating the Mitf to produce the pigment 
cells (see Chapter 128). Mitf is transcribed in the pigment-forming 
melanoblast cells that migrate from the neural crest into the skin and 
in the melanin-forming cells of the pigmented retina, but this protein 
is not functional until it receives signals to become active. The clue to 
these signals lay in two mouse mutants whose phenotypes resemble 
those of mice homozygous for microphthalmia mutations. Like those 
mice, homozygous White mice and homozygous Steel mice are white 
because their pigment cells have failed to migrate. Perhaps all three 
genes (Mitf, Steel, and White) are on the same developmental path­
way. In 1990, several laboratories demonstrated that the Steel gene
encodes a paracrine protein called stem cell factor (Witte, 1990). This 
factor binds to and activates the Kit RTK encoded by the White gene 
(Spritz et al., 1992; Wu et al., 2000). The binding of the stem cell 
factor to the Kit RTK dimerizes the Kit protein, causing it to become 
phosphorylated. Phosphorylated Kit activates the pathway whereby 
phosphorylated ERK is able to phosphorylate Mitf (Hsu et al., 1997; 
Hemesath et al., 1998). Only the phosphorylated form of Mitf is able 
to bind the p300/cyclic AMP response element-binding protein (CBP) 
coactivator protein, which enables it to activate transcription of the 
genes encoding tyrosinase and other proteins of the melanin-formation 
pathway (Price et al., 1998).
The Smad Pathway 
TGF-p Superfamily Proteins
There are more than 30 structurally related members of the TGF-P 
superfamily, and they regulate some of the most important interactions 
in development (see Chapter 31). The TGF-P superfamily includes the 
TGF-p family, the activin family, the bone morphogenetic proteins 
(BMPs), the Vgl family, and other proteins, including glial-derived 
neurotrophic factor (necessary for kidney and enteric neuron differ­
entiation) and Mullerian inhibitory factor (which is involved in mam­
malian sex determination).
TGF-p family members TGF-pi, -2, -3, and -5 are important in 
regulating the formation of the extracellular matrix between cells and 
for regulating cell division (both positively and negatively). The mem­
bers of the BMP family were originally discovered by their ability to 
induce bone formation; hence they are the BMPs. Bone formation, 
however, is only one of their many functions; they regulate cell divi­
sion, apoptosis (programmed cell death), cell migration, and differen­
tiation (Hogan, 1996).
Members of the TFG-P superfamily activate members of the Smad 
family of transcription factors (Heldin et al., 1997). The TGF-P ligand 
binds to a type II TGF-P receptor, which allows that receptor to bind 
to a type I TGF-p receptor. Once the two receptors are in close con­
tact, the type II receptor phosphorylates a serine or threonine on the 
type I receptor, thereby activating it. The activated type I receptor can 
now phosphorylate the Smad proteins. (Researchers named the Smad 
proteins by eliding the names of the first identified members of this 
family: the Caenorhabditis elegans Sma protein and the Drosophila 
Mad protein.) Smads 1 and 5 are activated by the BMP family of 
TGF-p factors, while the receptors binding activin and the TGF-P 
family phosphorylate Smads 2 and 3. These phosphorylated Smads
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bind to Smad 4 and form the transcription factor complex that will 
enter the nucleus. In vertebrates, the TGF-P superfamily ligand Nodal 
appears to activate the Smad pathway in those cells responsible for 
the formation of the mesoderm and for specifying the left-right axis 
(Nomura and Li, 1998). A mutation that constitutively activates BMP 
type I receptor ACVRl causes the inherited ectopic chondrogenesis 
and osteogenesis of fibrodysplasia ossificans progressiva (Shore et al., 
2006, see Chapter 56).
The JAK-STAT Pathway
Another important pathway transducing information on the cell mem­
brane to the nucleus is the JAK-STAT pathway (with JAK standing 
for “Janus kinase” and STAT for “signal transducer and activator of 
transcription”). Here the set of transcription factors consists of the 
STAT proteins (Ihle, 1996). STATs are phosphorylated by certain 
RTKs, including FGFRs and the JAK family of tyrosine kinases. The 
JAK-STAT pathway is extremely important in the differentiation of 
blood cells and the activation of the casein gene during milk produc­
tion. In casein production, for instance, the endocrine factor prolactin 
binds to the extracellular regions of prolactin receptors, causing them 
to dimerize. A JAK protein kinase is bound to each of the receptors (in 
their respective cytoplasmic regions), and these JAK proteins are now 
brought together, where they can phosphorylate the receptors at sev­
eral sites. The receptors are now activated and have their own protein 
kinase activity. Therefore the JAK proteins convert a receptor into an 
RTK. The activated receptors can now phosphorylate particular inac­
tive STATs and cause them to dimerize. These dimers are the active 
form of the STAT transcription factors; they are translocated into the 
nucleus, where they bind to specific regions of DNA. In this case, they 
bind to the upstream promoter elements of the casein gene, causing it 
to be transcribed.
The STAT pathway is very important in the regulation of human 
fetal bone growth. Mutations that prematurely activate the STAT path­
way have been implicated in some severe forms of dwarfism, such as 
the lethal thanatophoric dysplasia, wherein the growth plates of the rib 
and limb bones fail to proliferate. The genetic lesion resides in the gene 
encoding FGFR3, a receptor expressed in the cartilage precursor cells 
in the growth plates of the long bones (Rousseau et al., 1994; Shiang 
et al., 1994). Normally the FGFR3 protein is activated by an FGF; 
it signals the chondrocytes to stop dividing and begin differentiating 
into cartilage. This signal is mediated by the STATl protein, which is 
phosphorylated by the activated FGFR3 and then translocated into the 
nucleus. Inside the nucleus, this transcription factor activates the genes 
encoding a cell cycle inhibitor, the p21 protein (Su et al., 1997). The 
mutations causing thanatophoric dwarfism result in a gain-of-function 
phenotype, wherein the mutant FGFR3 is active constitutively—that 
is, without the need to be activated by an FGF (Deng et al., 1996; 
Webster and Donoghue, 1996).
The Wnt-p-Catenin Pathway 
Wnt-Family Proteins
The Wnts constitute a family of cysteine-rich glycoproteins. There 
are at least 15 members of this family in vertebrates (see Chapter 36). 
Their name comes from fusing the name of the Drosophila segment 
polarity gene wingless with int-1, the first cloned integration site for 
mouse mammary tumor virus. Although sonic hedgehog is important 
in patterning the ventral portion of the somites (causing the cells to 
become cartilage), Wntl appears to be active in inducing the dorsal 
cells of the somites to become muscle (McMahon and Bradley, 1990; 
Stern et al., 1995). Wnt proteins are also critical in establishing the 
polarity of insect and vertebrate limbs, and they are used in several 
steps of urogenital system development.
Members of the Wnt family of paracrine factors interact with trans­
membrane receptors of the Frizzled family (see Chapter 36). In the 
classical Wnt pathway, the binding of Wnt by the Frizzled protein 
causes the Frizzled protein to activate the Dishevelled protein. Once 
the Dishevelled protein is activated, it inhibits the activity of the gly­
cogen synthase kinase-3 (GSK-3) enzyme. GSK-3 is part of a protein
degradation complex that includes APC (adenomatous polyposis coli) 
and axin. If GSK-3 were active, it would prevent the dissociation of 
the p-catenin protein from the APC protein, which targets p-catenin 
for degradation. However, when the Wnt signal is given and GSK-3 
is inhibited, p-catenin can dissociate from the APC protein and enter 
the nucleus. Once inside the nucleus, it can form a heterodimer with 
the lymphocyte enhancer-binding factor (LEF) or T-cell factor (TCF), 
becoming a transcription factor. This complex binds to and activates 
the Wnt-responsive genes (Behrens et al., 1996; Cadigan and Nusse, 
1997). This model is undoubtedly an oversimplification (see McEwen 
and Peifer, 2001). One principle that is readily seen in the Wnt path­
way (and evident in the Hedgehog pathway) is that activation is often 
accomplished by inhibiting an inhibitor. Thus the GSK-3 protein is 
an inhibitor that is itself repressed by the Wnt signal. Mutation of the 
gene encoding Axin-2 causes an intriguing syndrome of tooth agenesis 
and colon cancer (Lammi et al., 2004).
In addition to sending signals to the nucleus, Wnt can affect the actin 
and microtubular cytoskeleton. Here, the Dishevelled protein interacts 
with a protein kinase that initiates a cascade that will phosphorylate 
cytoskeletal proteins and thereby alter cell shape, cell polarity (where 
the upper and lower portions of the cell differ), or motility (Witte et al., 
2010; Sepich et al., 2011; Ho et al., 2012).
The Hedgehog Pathway
Hedgehog Proteins
The Hedgehog proteins constitute a family of paracrine factors that 
are often used by the embryo to induce particular cell types and to 
create boundaries between tissues (see Chapter 27). Vertebrates have 
at least 3 homologues of the Drosophila hedgehog gene: Sonic hedge­
hog (Shh), Desert hedgehog (Dhh), and Indian hedgehog (Ihh). Desert 
hedgehog is expressed in the Sertoli cells of the testes, and mice homo­
zygous for a null allele of Dhh exhibit defective spermatogenesis. 
Indian hedgehog is expressed in the gut and cartilage and-is important 
in postnatal bone growth.
Sonic hedgehog is the most widely used of the three vertebrate 
homologues. Made by the notochord, it is processed so that only the 
amino-terminal two-thirds of the molecule is secreted. This peptide 
is responsible for patterning the neural tube such that motor neurons 
are formed from the ventral neurons and sensory neurons are formed 
from the dorsal neurons (Yamada et al., 1993). Sonic hedgehog is 
also responsible for patterning the somites so that the portion of the 
somite closest to the notochord becomes the cartilage of the spine (Fan 
and Tessier-Lavigne, 1994; Johnson et al., 1994). Sonic hedgehog is 
critical for the formation and maintenance of the facial midline, and 
several mutations of the Sonic hedgehog gene (or its receptor) cause 
holoprosencephaly (Maity et al., 2005). Sonic hedgehog mediates 
the formation of the left-right axis in several vertebrates, initiates the 
anterior-posterior axis in limbs, induces the regionally specific dif­
ferentiation of the digestive tube, and induces hair formation. Sonic 
hedgehog often works with other paracrine factors, such as Wnt and 
FGF proteins. In the developing tooth. Sonic hedgehog, FGF4, and 
other paracrine factors are concentrated in the region where cell inter­
actions create the cusps of the teeth (Vaahtokari et al., 1996).
Members of the Hedgehog protein family function by binding to a 
receptor called Patched. The Patched protein, however, is not a signal 
transducer. Rather, it is bound to a signal transducer, the Smoothened 
protein (Smo), and the Patched protein prevents Smo from function­
ing. In the absence of the Hedgehog protein binding to the Patched 
protein, Smo, inhibited by Patched, is inactive and the Cubitus inter- 
ruptus (Ci) protein (Glis Ito 3 in vertebrates) is tethered to the pri­
mary cilium of the responding cell. The primary cilium is a structure 
that protrudes from the cell surface and is formed from microtubules. 
While it is on the primary cilium, Ci is cleaved in such a way that a 
portion of it enters the nucleus and acts as a transcriptional repres­
sor. This portion of the Ci protein binds to the promoters and enhanc­
ers of particular genes and acts as an inhibitor of transcription. When 
Hedgehog binds to Patched, the Patched protein’s shape is altered such 
that it no longer inhibits Smo. Smo accumulates in the primary cilium
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and complexes with Evc2, a ciliary protein; this restricts Smo to local­
izing to a distinct ciliary compartment, the Eve zone. The localiza­
tion of the Smo-Evc2 complex leads to the dissociation of inhibitors 
Suppressor of Fused (SuFu) and protein kinase A from Ci. Active Smo 
signaling helps to transport Ci and SuFu to the tip of the primary cil- 
ium. This, in turn, allows Ci to dissociate from SuFu, and the intact 
Ci protein can now enter the nucleus, where it acts as a transcriptional 
activator of the same genes it used to repress (Aza-Blanc et al., 1997; 
Dorn et al. 2012).
The Hedgehog pathway is extremely important in limb and neural 
differentiation in vertebrates (see Chapters 28 to 35). Here the homo- 
logues of Ci are the Gli proteins. Both the transport of the Hedgehog 
protein and its reception by the target cell require cholesterol. Therefore 
mutations involving cholesterol metabolism and teratogens that block 
cholesterol synthesis can cause the same spectrum of defects as muta­
tions in Sonic hedgehog.
Juxtaposed Ligands and Receptors 
The Notch Pathway
Although most known regulators of induction are diffusible proteins, 
some inducing proteins remain bound to the inducing cell surface. In 
one such pathway, cells expressing the Delta, Jagged, or Serrate protein 
in their membranes activate neighboring cells that contain the Notch 
protein in cell membranes (see Chapter 72). Notch extends through the 
cell membrane; its external surface contacts Delta, Jagged, or Serrate 
proteins extending out from an adjacent cell. When complexed to 
one of these ligands. Notch undergoes a conformational change that 
enables it to be cut by the presenilin-1 protease. The cleaved portion 
enters the nucleus and binds to a dormant transcription factor of the 
CSL (CBFl, Suppressor of Hairless, Lag-1) family. When bound to 
the Notch protein, the CSL transcription factors activate their target 
genes (Lecourtois and Schweisguth, 1998; Schroeder et al., 1998; 
Struhl and Adachi, 1998).
Notch proteins are extremely important receptors in the nervous 
system. In both the vertebrate and Drosophila nervous systems, the 
binding of Delta to Notch tells the receiving cell not to become neural 
(Chitnis et al, 1995; Wang et al., 1998). In the vertebrate eye, the inter­
actions between Notch and its ligands seem to regulate which cells 
become optic neurons and which become glial cells (Dorsky et al., 
1997; Wang et al, 1998).
Eph Receptors and Ephrins
Eph receptors are the largest subfamily of RTK receptors. Their 
ligands, ephrins, form a family of related proteins. Both the receptors 
and ligands are bound to plasma membrane. Eph/ephrin signaling is 
bidirectional: both receptors and ligands can induce signal transduc­
tion. Eph receptor activation of ephrin ligand is c&W&i forward signal­
ing, and ligand-activation of Eph receptor is called reverse signaling. 
Eph receptors and ephrins can interact between two opposing cells, 
termed trans interactions, or it can happen within one cell, termed cis 
interactions (Arvanitis and Davy, 2008).
Eph receptors and ephrins are expressed widely in the developing 
embryo, and they play important physiological roles in the adult as 
well. What makes their biological functions wide and varied is the 
ability of Eph/ephrins to interact with other cell surface receptors, 
adhesion proteins, and channels and pores such as gap junctions and 
the ion channels found in synapses (Arvanitis and Davy, 2008).
In Xenopus FGF and EphrinBl signaling regulated the migration 
of retinal progenitor cells into the eye domain within the anterior 
neural plate. FGF signaling represses the cell migration into the eye 
domain, and EphrinBl reverse signaling promotes it (Moore et al., 
2004). Moore and colleagues also show that Fgfrl and EphrinBl are 
coexpressed at the anterolateral borders of the eye domain, and that 
EphrinBl reverse signaling can rescue the FGF repression of retinal 
cell fate caused, for instance, by constitutively active Fgfr2. This Fgf 
and Ephrin signaling may be due to direct interactions, because Fgfr 
can associate with the cytoplasmic tail of the EphrinB 1 in Xenopus and 
induce phosphorylation of EphrinBl (Chong et al., 2000). The pro­
genitor cell movements are critical for retinal cell fate as the ectopic
expression of eye-specifying transcription factor Pax6 in blastomere 
cells; these are not normally destined to become retinal cells do not 
adopt a retinal cell fate unless they have migrated into the eye domain 
(Kenyon et al., 2001; Moody, 2004).
THE EXTRACELLULAR MATRIX AS A SOURCE 
OF CRITICAL DEVELOPMENTAL SIGNALS
Extracellular Matrix Proteins and Functions
The extracellular matrix consists of macromolecules secreted by cells 
into their immediate environment (see Chapter 163). These macromol­
ecules form a region of noncellular material in the interstices between 
the cells. The extracellular matrix is a critical region for much of ani­
mal development. Cell adhesion, cell migration, and the formation of 
epithelial sheets and tubes all depend on the ability of cells to form 
attachments to extracellular matrices. In some cases, as in the forma­
tion of epithelia, these attachments have to be extremely strong. In 
other instances, as when cells migrate, attachments have to be made, 
broken, and made again. In some cases the extracellular matrix merely 
serves as a permissive substrate to which cells can adhere or upon 
which they can migrate. In other cases, it provides the directions for 
cell movement or the signal for a developmental event.
Extracellular matrices are made up of collagen, proteoglycans, and 
a variety of specialized glycoprotein molecules such as fibronectin and 
laminin. These large glycoproteins are responsible for organizing the 
matrix and cells into an ordered structure. Fibronectin plays an impor­
tant role in cell migration. The “roads” over which certain migrating 
cells travel are paved with this protein. Fibronectin paths lead germ 
cells to the gonads and lead heart cells to the midline of the embryo. 
If chick embryos are injected with antibodies to fibronectin, the heart­
forming cells fail to reach the midline and two separate hearts develop 
(Heasman et al., 1981; Linask and Lash, 1988).
Laminin and type IV collagen are major components of a type of 
extracellular matrix called the basal lamina, which is characteristic 
of the closely knit sheets that surround epithelial tissue. Adhesion of 
epithelial cells to laminin (upon which they sit) is much greater than 
the affinity of mesenchymal cells for fibronectin (to which they must 
bind and release if they are to migrate). Like fibronectin, laminin plays 
a role in assembling the extracellular matrix, promoting cell adhe­
sion and growth, changing cell shape, and permitting cell migration 
(Hakamori et al., 1984).
Bissell and colleagues (1982; Martins-Green and Bissell, 
1995) have shown that the extracellular matrix is also capable of 
inducing specific gene expression in developing tissues—especially 
those of the liver, testis, and mammary gland—in which the induction 
of specific transcription factors depends on cell-substrate binding 
(Liu et al., 1991; Streuli et al., 1991; Notenboom et al, 1996). Often 
the presence of bound integrin (the cell membrane receptor for fibro­
nectin and other extracellular matrix molecules) prevents the activa­
tion of genes that specify apoptosis (Montgomery et al., 1994; Frisch 
and Ruoslahti, 1997). The chondrocytes that produce the cartilage 
of our vertebrae and limbs can survive and differentiate only if they 
are surrounded by an extracellular matrix and joined to that matrix 
through their integrins (Hirsch et al., 1997). If chondrocytes from the 
developing chick sternum are incubated with antibodies that block the 
binding of integrins to the extracellular matrix, they shrivel up and 
die. Endo et al. (2012) have shown that direct interactions between 
the extracellular matrix protein anosmin and Fgf8, Bmp5 and Wnt3a 
in anterior neural folds ensure correct local doses of these paracrine 
factors to form the cranial neural crest and thus ultimately normal 
craniofacial morphogenesis. In humans, mutations in anosmin cause 
X-linked Kallmann syndrome which includes anosmia and craniofa­
cial defects (Legouis et al., 1991)
The extracellular matrix may play especially important roles in 
mediating the branching of parenchymal organs. Lin and colleagues 
(2001) showed that murine kidney and lung mesenchymes induce col­
lagen XVIII in different places on the epithelium of murine kidneys 
and lungs and that this expression is predictive of the branching pattern 
of the epithelia.
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Recent experiments (Cota and Davidson, 2015) demonstrate that 
the extracellular matrix can be critical in creating divergent cell types 
from a common precursor cell. In the tunicate dona, Fgf signals 
appear to tell the matrix-bound cell of a dividing pair to become a 
heart precursor, but its sister cell is destined to become a pharynx 
cell. It appears that the adherent cell membrane is able to keep and 
trap Fgf receptors via integrin and caveolin. In this way, the matrix- 
bound cell is able to respond to the Fgf, while the non-adherent sister 
cell is not.
CELL DEATH PATHWAYS
Programmed cell death, or apoptosis, is a normal part of development. 
In the nematode C. elegans, in which we can count the number of 
cells, exactly 131 cells die according to the normal developmental pat­
tern. All of the cells of this nematode are “programmed” to die unless 
they are actively told not to undergo apoptosis. In humans, as many as 
10“ cells die in each adult each day and are replaced by other cells. 
(Indeed, the mass of cells we lose each year through normal cell death 
is close to our entire body weight.) While a human individual is still 
within the uterus, he or she is constantly making and destroying cells, 
generating about 3 times as many neurons as he or she eventually ends 
up with at birth.
By the time 1 was bom, more of me had died than survived. It was
no wonder 1 cannot remember; during that time 1 went through
brain after brain for nine months, finally contriving the one model
that could be human, equipped for language. (Thomas, 1992)
Apoptosis is necessary not only for the proper spacing and orienta­
tion of neurons but also for generating the middle ear space, the vagi­
nal opening, and the spaces between our fingers and toes (Saunders 
and Fallon, 1966; Rodrigez et al., 1997; Roberts and Miller, 1998). 
Apoptosis prunes away unneeded structures, controls the number of 
cells in particular tissues, and sculpts complex organs. Different tis­
sues use different signals for apoptosis. One of the signals often used in 
vertebrates is BMP4. Some tissues, such as connective tissue, respond 
to BMP4 by differentiating into bone. Others, such as the surface ecto­
derm, respond to BMP4 by differentiating into skin. Still others, such 
as neural crest cells and tooth primordia, respond by degrading their 
DNA and dying. In the developing tooth, for instance, numerous GDFs 
are secreted by the enamel knot. After the cusp has grown, the enamel 
knot synthesizes BMP4 and shuts itself down by apoptosis (Vaahtokari 
et al., 1996).
Cells are programmed to die in several tissues; they will remain 
alive only if some growth or differentiation factor is present to “res­
cue” them. This happens during the development of mammalian red 
blood cells. The red blood cell precursors in the mouse liver need 
the hormone erythropoietin to survive. If they do not receive it, they 
undergo apoptosis. The erythropoietin receptor works through the 
JAK-STAT pathway, activating the Stat5 transcription factor (Bittorf 
et al., 2000; Socolovsky et al., 2001). In this way the amount of eryth­
ropoietin that is present can determine how many red blood cells enter 
the circulation.
One of the pathways for apoptosis was largely delineated through 
genetic studies of C. elegans. It was found that the cell death abnormal 
(ced) proteins encoded by the ced-3 and ced-4 genes were essential for 
apoptosis; however, in the cells that did not undergo apoptosis, those 
genes were turned off by the product of the ced-9 gene (Hengartner 
et al., 1992). The CED-4 protein is a protease activating factor that 
activates CED-3, a protease that initiates the destruction of the cell. 
Mutations that inactivate the CED-9 protein cause numerous cells that 
would normally survive to activate their ced-3 and ced-4 genes and 
die. This leads to the death of the entire embryo. Conversely, gain-of- 
function mutations of ced-9 cause the CED-9 protein to be made in 
cells that would otherwise die. Thus, the ced-9 gene appears to be a 
binary switch that regulates the choice between life and death on the 
cellular level. It is possible that every cell in the nematode embryo is 
poised to die and that those cells that survive are rescued by activation 
of the ced-9 gene.
The CED-3 and CED-4 proteins form the center of the apoptosis 
pathway that is common to all animals studied. The trigger for apop­
tosis can be a developmental cue, such as a particular molecule (e.g., 
BMP4 or glucocorticoids) or the loss of adhesion to a matrix. Either 
type of cue can activate the CED-3 or CED-4 protein or inactivate the 
CED-9 molecules. In mammals, the homologues of the CED-9 protein 
are members of the Bcl-2 family of genes. This family includes BCL- 
2, Bcl-X, and similar genes. The functional similarities are so strong 
that if an active human BCL-2 gene is placed into C. elegans embryos, 
it prevents normally occurring cell deaths in the nematode embryos 
(Vaux et al., 1992). In vertebrate red blood cell development (men­
tioned previously), the StatS transcription factor activated by erythro­
poietin functions by binding to the promoter of the Bcl-X gene, where 
it activates the synthesis of that antiapoptosis protein (Socolovsky 
et al., 1999).
The mammalian homologue of CED-4 is called Apaf-1 (apoptotic 
protease activating factor-1); it participates in the cytochrome C- 
dependent activation of the mammalian CED-3 homologues caspase- 
9 and caspase-3 (Shaham and Horvitz, 1996; Cecconi et al., 1998; 
Yoshida et al., 1998). Activation of the caspases causes autodiges­
tion of the cell. Caspases are strong proteases, and they digest the 
cell from within. The cellular proteins are cleaved and the DNA is 
fragmented.
Although apoptosis-deficient nematodes deficient for CED-4 are 
viable (despite their having 15% more cells than wild-type worms), 
mice with loss-of-function mutations for either caspase-3 or caspase-9 
die around birth from massive cell overgrowth in the nervous system 
(Kuida et al., 1996, 1998; Jacobson et al., 1997). Mice homozygous 
for targeted deletions of Apaf-1 have severe craniofacial abnormali­
ties, brain overgrowth, and webbing between their toes.
In mammals there is more than one pathway to apoptosis. Apoptosis 
of the lymphocytes, for instance, is not affected by the deletion of 
Apaf-1 or caspase-9 and works by a separate pathway initiated by 
the CD95 protein. Different caspases may function in different cell 
types to mediate the apoptotic signals (Hakem et al., 1998; Kuida 
et al., 1998). One of the most interesting involves the “death domain,” 
containing receptors of the tumor necrosis factor (TNF) family. These 
receptors can induce apoptosis in several cell systems, and they appear 
to accomplish this by blocking the antiapoptosis signals sent by other 
factors. It is likely that the death domain binds a phosphatase that 
cleaves the phosphates from the RTKs, which would be activated by 
the antiapoptotic signal (Daigle et al., 2002). This prevents their acti­
vation and allows apoptosis to commence.
Just as developmental signals (e.g., BMP4) can be used by some 
cells for apoptosis, so the death domain receptors can, in some 
instances, be used for nonapoptotic development. One of the devel- 
opmentally important TNF receptors with a death domain is Edar, a 
protein required for the development of hair, teeth, and other cutane­
ous appendages. Mutations of this or of its ligand, Eda, cause hypohi- 
drotic epidermal dysplasia, a syndrome characterized by lack of sweat 
glands, sparse hair, and poorly formed teeth. An identical syndrome 
is also produced by a deficiency of the adapter protein that binds the 
death domain of this receptor. In this instance, instead of producing 
cell death, activation of the receptor enables continued development 
(Headon et al., 2001).
THE NATURE OF GENETIC SYNDROMES 
Pleiotropy
Research on the expression patterns of transcription factors and para­
crine factors has suggested mechanisms that explain some of the 
genetic syndromes wherein mutations at a single genetic locus can 
cause numerous different malformations. The production of several 
conditions by mutations at one locus is called pleiotropy. For instance, 
in humans and mice, heterozygosity for MITF deficiency causes a 
condition that involves iris defects, pigmentation abnormalities, deaf­
ness, and an inability to produce the normal number of mast cells (see 
Fig. 2-lB). The skin pigment, the iris of the eye, the inner ear tissue, 
and the mast cells of the immune system are not related to one another
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in such a way that the absence of one would produce the absence of 
the others. Rather, all 4 parts of the body independently use the MITF 
protein as a transcription factor. This type of pleiotropy has been called 
mosaic pleiotropy because the relevant organ systems are separately 
affected by the abnormal gene function.
Whereas the eye pigment, body pigment, and mast cell features 
of MITF deficiency are separate events, other features of the syn­
drome are not. For instance, the failure of MITF expression in the 
pigmented retina prevents this structure from fully differentiating. 
This, in turn, causes a malformation of the choroid fissure of the 
eye, resulting in drainage of the vitreous humor fluid. Without this 
fluid, the eye fails to enlarge (hence the name microphthalmia, which 
means “small eye”). This phenomenon, in which several developing 
tissues are affected by the mutation even though they do not express 
the mutated gene, is called relational pleiotropy (see Griineberg, 
1938, 1962).
Genetic Heterogeneity
Another important feature of syndromes is that mutations in differ­
ent genes can produce the same phenotype. If the genes are part of 
the same signal-transduction pathway, a mutation in any of them can 
give a similar result. The phenomenon whereby mutations in different 
genes produce similar phenotypes is called genetic heterogeneity. For 
example, cyclopia can be produced by mutations in the Sonic hedge­
hog gene or by mutations in cholesterol synthesis genes. Since they are 
in the same pathway, mutations in one gene generate a phenotype simi­
lar or identical to mutations in the other genes. Similarly, as we saw 
earlier, mutations in EDA (ligand), EDAR (receptor) or EDARADD 
(adapter protein) gave the same phenotype of hypohidrotic ectodermal 
dysplasia (Headon et al., 2001).
Mechanisms of Dominance
Whether a syndrome is dominant or recessive can now be explained at 
the molecular level. First, many syndromes are referred to as “domi­
nant” only because the homozygous condition is lethal to the embryo 
and the fetus never survives. Therefore the homozygous condition 
never exists. Second, there are at least 4 ways of achieving a dominant 
phenotype.
The first mechanism of dominance is haploinsufficiency. This 
merely means that one copy of the gene (the haploid condition) is not 
enough to produce the required amount of product for normal develop­
ment. For example, individuals with Waardenburg syndrome type II 
have roughly half the wild-type amount of MITF. This is not enough 
for full pigment cell proliferation, mast cell differentiation, or inner ear 
development. Thus an aberrant phenotype results when only 1 of the 2 
copies of this gene is absent or nonfunctional.
The second mechanism of dominance is gain-of-function mutations. 
As mentioned earlier, thanatophoric dysplasia (as well as milder forms 
of dwarfism, such as achondroplasia) results from a mutation causing 
the FGFR to be constitutively active. This activity is enough to cause 
an anomalous phenotype to develop.
The third mechanism of dominance is a dominant-negative allele. 
This situation can occur when the active form of the protein is a multi- 
mer and all proteins of the multimer have to be of the wild type for the 
protein to function. A dominant-negative allele is the cause of Marfan 
syndrome, a disorder of the extracellular matrix. This syndrome is 
associated with anomalies of the joints and connective tissues, not all 
of which are necessarily disadvantageous. Increased height, dispropor­
tionately long limbs and digits, and mild-to-moderate joint laxity are 
characteristic. However, patients with Marfan syndrome also experi­
ence vertebral column deformities, myopia, loose lenses, and (most 
importantly) aortic problems that may lead to an aneurysm (bursting 
of the aorta) later in life. The mutation is in the gene for fibrillin, a 
secreted glycoprotein that forms multimeric microfibrils in elastic con­
nective tissue. The presence of even small amounts of mutant fibril­
lin prohibits the association of wild-type fibrillin with microfibrils. 
Eldadah and colleagues (1995) have shown that when a mutant human 
gene for fibrillin is transfected into fibroblast cells that already con­
tain two wild-type genes, incorporation of fibrillin into the matrix is 
inhibited.
The fourth mechanism of dominance involves subunit interac­
tions wherein the dimer made from the products of 2 different alleles 
is superior in function to dimers made exclusively of the product of 
either allele (Trehan and Gill, 2002).
MODULARITY AND CONTEXTUALITY
During the development of mammals, there are domains set off by the 
expression of transcription factors. These regions can interact, thereby 
activating the expression or function of another set of transcription 
factors. These can further subdivide the domains, or they can initiate 
the expression of those batteries of genes that cause the differentiated 
proteins of the particular cell type to emerge. This concept is known 
as modularity. Development occurs through a series of discrete and 
interacting modules (Riedl, 1978; Gilbert et al., 1996; Raff, 1996; 
Davidson, 2001). In development, such modules include physical 
modules (e.g., hair follicles and teeth), morphogenetic fields (e.g., 
those described for the limb or eye), and physical structures for which 
there are no adult counterparts (e.g., rhombomeres). Modular units 
allow certain parts of the body to change without interfering with the 
functions of other parts.
These fields often provide the genes and proteins with their context. 
For instance, as already mentioned, BMP4 can be a signal for bone 
development (in somites), apoptosis (in the neural and derivatives), 
epidermis formation (in the induction of the ectoderm), or lens forma­
tion (within the eye). What it does depends on the field in which it 
is expressed. Unlike the genes for globin or chymotrypsin, the genes 
expressed early in development are often used for multiple functions. 
In some instances these functions can depend on very different proper­
ties of the molecule. p-Catenin can play a role on the cell membrane 
as part of an adhesion complex, or it can play a role in the nucleus 
as a transcription factor. Similarly a protein that functions as an eno- 
lase or alcohol dehydrogenase enzyme in the liver can function as a 
structural crystallin protein in the lens (Piatigorsky and Wistow, 1991). 
Developmental genes work within specific contexts.
Phenotypic Heterogeneity
These contexts can also determine the effect of a particular gene. It is 
not uncommon in the context of clinical genetics to identify a mutant 
allele that produces a mildly abnormal phenotype in one generation 
and a more abnormal phenotype in another generation. A mutant gene 
that produces limblessness in one generation can produce only a mild 
thumb abnormality in the next (Freire-Maia, 1975). Indeed, by fol­
lowing the phenotypes produced in different members of the same 
family, one can see that the same gene can produce different phe­
notypes depending on the other genes that are present (Wolf, 1995, 
Nijhout and Paulsen, 1997). There are even cases where the pheno­




Morphogenesis involves changes in cell behavior. There are 2 main 
groups of cells in the embryo: epithelial cells, which are tightly con­
nected to one another in sheets or tubes, and mesenchymal cells, 
which are unconnected to each other and operate as individual units. 
Morphogenesis is brought about through a limited repertoire of cel­
lular processes in these 2 classes of cells: (1) the direction and number 
of cell divisions, (2) changes in cell shape, (3) cell movement, (4) cell 
growth, (5) cell death, and (6) changes in the composition of the cell 
membrane and extracellular matrix. How these processes are accom­
plished can differ between mesenchymal and epithelial cells (Table 2-3; 
see Larsen, 1997).
Three important morphogenetic events—the orientation of cell divi­
sion, the orientation of cell polarity, and cell migration—are regulated 
through the cytoskeleton. The orientation and number of cell divi­
sions are tightly regulated. Given the similarity of facial appearance 
within a family, it seems that such regulation is under genetic control.
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Table 2-3. The Morphogenetic Repertoire.
Cell Type Property Mechanism Example
Mesenchyme Movement Contact guidance Amphibian gastralation
(and nerves)
Haptotaxis Cell movement in vitro
Contact inhibition/
Retinal cells mapping to 
tectum
NC invasion of cornea
Space






Loss of rniillerian duct
Condensation Migration Ganglion formation
Adhesion Dermal condensations
Growth Theoretical
Traction Cell aggregation in vitro










Bending of sheet Neural fold formation



















ECM, extracellular matrix; NC, neural cell 
Source: J. Bard, personal communication.
The direction of cell divisions is controlled by the orientation of the 
mitotic spindle. This, in turn, is regulated by the cytoskeleton of the 
cell, especially by the dynein-rich cortex (O’Connell and Wang, 2000; 
Dujardin and Vallee, 2002). The positioning of the cytoskeleton can be 
effected by cell-cell contacts or by paracrine factors such as Wnt pro­
teins (Goldstein, 2000; Le Borgne et al., 2002). Both appear to work 
by causing changes in the cytoskeleton.
Changes in cell shape allow for morphogenesis in several ways. 
Many morphogenetic processes, such as neurulation, are caused by 
changes in the shape of cells. In neurulation, this is especially impor­
tant for the formation of the neural tube (Smith and Schoenwolf, 1997; 
Zolessi and Arruti, 2001). In mammals, changes in cell shape are also 
critical for the formation and polarity of the trophectoderm (Kidder, 
2002). Such changes are also mediated through the cytoskeleton.
There are several mechanisms that enable cells to migrate from 
one region of the body to another. These mechanisms involve interac­
tions of the cell surfaces with molecules that give cues as to when to 
start migrating, where to go, and when to cease migration. Migration 
is dependent on both the actin cytoskeleton and the ATPases (e.g., 
dynein) that drive it. Defects in the regulation of these systems, such as 
in lissencephaly-1, where the regulation of dynein in certain neuronal 
precursors is defective (Vallee et al., 2001), result in defective migra­
tion. There are two major modes of cell migration, and they are often 
combined. One mode is to follow a gradient of chemotactic molecules
to its source. The other mode is to follow a particular substrate pathway. 
In addition to attractive signals, repulsive signals also can occur.
Chemotaxis is defined as cellular locomotion directed in response to 
a concentration gradient of a chemical factor in solution. Cells sense 
the chemical and migrate toward higher concentrations of it until 
they reach the source secreting it. In the vertebrate lung, brain, and 
limb, FGFs function as chemotactic proteins (Park et al., 1998; Li and 
Muneoka, 1999; Kubota and Ito, 2000). Failure of chemotaxis is found 
in several systems, especially those affecting the cytoskeleton of neu­
ral cells and lymphocytes.
Gradients do not have to be in solution. An adhesive molecule 
could be present in increasing amounts along an extracellular matrix. 
A cell that was constantly making and breaking adhesions with such 
a molecule would move from a region of low concentration to an area 
where that adhesive molecule was more highly concentrated. Such a 
phenomenon is called haptotaxis (Curtis, 1969^ Migration of the pro- 
nephric duct cells in salamanders is regulated by haptotaxis (Zackson 
and Steinberg, 1987; Drawbridge et al., 1995). Moreover, certain 
human genetic conditions appear to have bases in the haptotactic 
mode of migration. In Kallmann syndrome, for instance, the protein 
anosmin is absent. This protein plays a key role in the migration of 
gonadotropin-releasing hormone neurons and olfactory nerves to the 
hypothalamus, and it is thought to be part of the extracellular matrix 
(Soussi-Yanicostas etal., 1996).
RANDOMNESS AND CHANCE IN MORPHOGENESIS
There are numerous sources of randomness in the human phenotype. 
In addition to somatic mutation and recombination, the major sources 
of chance are (1) X-chromosome inactivation, (2) stochastic interac­
tions, and (3) environmental induction.
X-Chromosome Inactivation
In female mammals, including humans, one X chromosome in each 
cell is inactive while the other X chromosome is active. Very early in 
the development of human females, both X chromosomes are active; 
but as development proceeds, one X chromosome is turned off in each 
cell. Moreover, this inactivation is random. In some cells, the paternally 
derived X chromosome is inactivated; in other cells, the maternally 
derived X chromosome is shut off. This process is irreversible. Once an 
X chromosome has been inactivated, the same X chromosome is inac­
tivated in all of that cell’s progeny. As X inactivation happens relatively 
early in development, an entire region of cells derived from a single 
cell may have the same X chromosome inactivated. Thus, all tissues in 
female mammals are mosaics of 2 cell types (see Migeon, 1994).
If one of the X chromosomes contains a mutant allele and the other 
does not, the pattern of inactivation can produce different phenotypes. 
There are several cases of monozygous twins who are heterozygous 
for an X-linked form of muscular dystrophy. Most heterozygous 
women do not express any symptoms because the cells expressing the 
wild-type allele can compensate for the cells expressing the mutant 
allele. However, if by chance the wild-type allele is on the inactivated 
X chromosome in a large proportion of a woman’s muscle cells, she 
will manifest the disease. There have been several instances where 
one girl showed the symptoms of the disease whereas her monozy­
gous twin sister did not (Pena et al., 1987; Norman and Harper, 1989; 
Richards et al., 1990; Tremblay et al., 1993). Similarly, there are cases 
where monozygous female twins are discordant with respect to color 
blindness or Hunter syndrome owing to X-chromosome inactivation 
(Jorgensen et al., 1992; Winchester et al., 1992).
Stochastic Variation
Many events in the body are the products of both chance and necessity. 
The vascularization of the body differs even between identical twins, 
as do the intimate details of neural connection, lymphocyte repertoire, 
and iris pattern (see Daugman and Downing 2001). Even in relatively 
simple animals that are genetically identical and are given the same 
homogeneous environment, differences can be seen. The Bristol N2 
strain of C. elegans has an invariant cell lineage (the cell divisions that 
occur between the fertilized egg and the adult are largely identical and
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always produce the same set of tissues), an invariant nervous system 
whose 302 neurons have reproducible synaptic connectivity, and an 
invariant genotype. Moreover, this strain of C. elegans has a repertoire 
of behaviors that it performs in a very limited environment, a flat agar 
surface supplied with a uniform pad of identical bacteria. However, this 
behavior is not uniform. Jorgensen et al. (1992) isolated mutants most 
of which were seen to lie straight in a paralyzed manner. However, a 
fraction of the worms consistently took on a quite different “curly” 
posture. Such differences in a cloned population might be caused by 
slight differences in neural connectivity, which could be caused by 
stochastic developmental effects (see Schnabel, 1997). The nervous 
system seems to encourage such differences by the “winner take all” 
mechanisms caused by Hebbian rules of neuronal connections.
Environmental Determination of Phenotype
In addition to its role in immunocyte differentiation, the environ­
ment plays other significant roles in phenotype production. Obviously 
starvation or overeating will change an individual’s phenotype, and 
there are likely to be genes that respond to dietary factors and produce 
diseases such as diabetes and coronary artery disease. These are dis­
eases wherein genes interact with environmental conditions to create 
the pathological states. There are some genetic conditions that can be 
completely abolished by dietary supplementation. Foremost among 
these is gulonolactone oxidase deficiency (hypoascorbemia, OMIM 
240400), a mutation in the gulonolactone oxidase gene on the short 
arm of chromosome 8, which causes a syndrome that produces death 
in childhood due to connective tissue malfunction. Gulonic acid oxi­
dase is the final enzyme in the pathway leading to ascorbic acid, and 
although most mammals have this enzyme and can synthesize vita­
min C, our genes for it are mutated and we cannot make this necessary 
compound. Without vitamin C replacement therapy from the environ­
ment, each of us would die.
Environment can also be extremely important in modulating the 
effects of mutant alleles. The fetuses most at risk for neural tube 
defects appear to be those with mutations in genes associated with 
folate metabolism (Whitehead et al., 1995; De Marco et al., 2000). 
Folate is a critical substrate for the methylation of homocysteine to 
methionine, but the mechanisms by which folate deficiency interferes 
with neural tube closure are not known. Smith-Lemli-Opitz syndrome 
and phenylketonuria are 2 other conditions wherein the environment 
interacts with genetics to produce the phenotype. In Smith-Lemli- 
Opitz syndrome (Chapter 28), dietary cholesterol can offset the mutant 
alleles that prevent proper cholesterol synthesis. In phenylketonuria, 
the behavioral and cognitive deficiencies associated with this syn­
drome can be ameliorated by dietary restriction of phenylalanine.
It is also possible that interactions between the environment and 
our genome control some part of our facial phenotype. Physical stress 
from the environment is needed to produce bones such as the mamma­
lian patella and the bird fibular crest (Muller and Steicher, 1989; Wu, 
1996). Corruccini (1984) and Varrela (1992) have speculated that the 
reason that nearly a quarter of our population needs orthodontic appli­
ances is that our children’s mild-textured diet causes the lower jaw to 
develop abnormally. Increased chewing causes tension that stimulates 
growth of the mandible bone and muscle (Kiliardis et al., 1985; Weijs 
and Hillen, 1986). The placement of young primates on a soft diet 
will cause malocclusions in their jaws, similar to that seen in humans 
(Corruccini and Beecher, 1982, 1984).
One of the most important changes that the environment can effect 
in mammalian development concerns DNA methylation. The “Barker 
hypothesis” (Barker, 1995) postulates that certain anatomical and 
physiological parameters get “programmed” during embryonic and
fetal development and that changes in nutrition during this time can 
produce permanent changes in the pattern of metabolic activity. These 
changes can predispose the adult to particular diseases. Specifically 
epidemiological studies have suggested that the adult offspring of 
mothers who experienced protein deprivation during certain months 
of pregnancy (owing to wars, famines, or migrations) were at high 
risk for developing hypertension, heart disease, and diabetes as adults.
Although some of these changes may be anatomical (a low-protein 
diet might not allow the kidney to construct as many nephrons as it 
would build on a protein-rich diet), other changes may involve methyl­
ation differences that “set” the metabolic levels of the adult. Lillycrop 
and colleagues (2005) have shown that rats born of mothers having a 
low-protein diet had a different pattern of liver gene methylation than 
did the offspring of mothers fed a diet with a normal amount of protein 
and that these differences in methylation changed the metabolic profile 
of the rat’s liver. For instance, the methylation of the promoter region of 
the PPARa gene (a gene that is critical in the regulation of carbohydrate 
and lipid metabolism) is 20% lower in those rats fed protein-restricted 
diets and its transcriptional activity is 10-fold greater. Moreover, the 
difference between these methylation patterns could be abolished by 
including folic acid in the protein-restricted diet. Thus the difference in 
methylation results from changes in folate metabolism caused by the 
limited amount of protein available to the fetus. It appears, then, that 
prenatal nutrition can induce long-lasting gene-specific alterations in 
transcriptional activity and metabolism. Similarly, genetically identi­
cal mice, each having the viable Agouti allele, had different patterns of 
pigmentation and obesity depending on the methyl supplementation of 
their mother’s diet during pregnancy (Waterland and Jirtle, 2003). This 
was found to be regulated by the methylation of a regulatory region of 
the viable Agouti gene.
DNA methylation differences arise during the lifetimes of mono­
zygotic twins. Moreover, such differences increase with time and are 
reflected in different gene expression patterns (Fraga et al., 2005). 
Thus different phenotypes can arise from identical genotypes through 
environmental interactions. This was demonstrated experimentally by 
depriving rats of maternal care during the first week of postnatal life. 
Those rats that had low maternal care were more anxious as adults. 
This was found to be correlated with the failure of the glucocorticoid 
receptor to become expressed in the hippocampus of these rats. This 
hippocampal expression failure, in turn, was found to be caused by 
the methylation of a particular cytosine in the regulatory region of the 
glucocorticoid receptor gene. This methylation prevented the binding 
of the Egr-1 transcription factor found in the brain and the prevention 
of transcription from these brain cells (Weaver et al., 2004, 2005).
The production of phenotype from genotype is regulated at numer­
ous gene expression levels: at the levels of gene transcription, mRNA 
processing, mRNA translation, and posttranslational modification. It 
is further controlled by cell-cell and cell-substrate interactions and by 
environmental influences. At all of these levels, the vectors of regulation 
work both ways. A cell’s fate is determined both by the gene expression 
within it and the community of cells in which it resides. Even the envi­
ronment can alter patterns of gene expression; in the production of the 
human phenotype, experience is added to endowment (Childs, 1999).
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